Pricing Log in Create free account

Adaptimmune Therapeutics PLC (ADAPY) vs aTyr Pharma, Inc. (ATYR)

Adaptimmune Therapeutics PLC and aTyr Pharma, Inc. are both Biotechnology companies. Adaptimmune Therapeutics PLC and aTyr Pharma, Inc. are of similar size ($14.8M and $14.6M). aTyr Pharma, Inc. grew revenue faster over the last twelve months: 6.78% against −54.0%. aTyr Pharma, Inc. has the higher net margin (0.00% vs −262.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, aTyr Pharma, Inc. leads on 9 and Adaptimmune Therapeutics PLC on 7.

Valuation

Metric ADAPY ATYR Biotechnology median
P/E n/m n/m 10.60
P/S 0.08 1.38 9.40
P/B n/m 0.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.61 0.66
EV/Sales 0.08 (3.49) 9.02
Earnings yield (3,250.00%) (397.17%) (32.88%)
Free cash flow yield (3,648.13%) (355.97%) (23.13%)

Profitability

Metric ADAPY ATYR Biotechnology median
Gross margin 94.81% 1.72% 68.51%
Operating margin (427.75%) 0.00% 0.00%
Net margin (262.46%) 0.00% 0.00%
Free cash flow margin (294.49%) 0.00% 0.00%
Return on equity (1,349.52%) (98.67%) (51.96%)
Return on assets 0.00% (70.97%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAPY ATYR Biotechnology median
Revenue growth (TTM) (53.99%) 6.78% 6.76%
EPS growth (last fiscal year) 142.86% 7.54% 29.88%
Revenue growth, 5-year CAGR 8.40% (14.75%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAPY ATYR Biotechnology median
Debt to equity (0.36) 0.00 0.00
Current ratio 1.52 5.12 4.97
Net debt to EBITDA 0.47 1.01 1.01

Dividend

Metric ADAPY ATYR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAPY ATYR Biotechnology median
Market cap 14.55m 14.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack